IRIS Accounts Production v23.2.0.158 10907715 Board of Directors 1.9.22 31.8.23 31.8.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh109077152022-08-31109077152023-08-31109077152022-09-012023-08-31109077152021-08-31109077152021-09-012022-08-31109077152022-08-3110907715ns10:Originalns15:EnglandWales2022-09-012023-08-3110907715ns14:PoundSterlingns10:Original2022-09-012023-08-3110907715ns10:Originalns10:Director12022-09-012023-08-3110907715ns10:Original2022-09-012023-08-3110907715ns10:Original2023-08-3110907715ns10:Originalns10:PrivateLimitedCompanyLtd2022-09-012023-08-3110907715ns10:Originalns10:SmallEntities2022-09-012023-08-3110907715ns10:Originalns10:AuditExempt-NoAccountantsReport2022-09-012023-08-3110907715ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-09-012023-08-3110907715ns10:SmallCompaniesRegimeForAccountsns10:Original2022-09-012023-08-3110907715ns10:Originalns10:FullAccounts2022-09-012023-08-3110907715ns10:Originalns10:Director22022-09-012023-08-3110907715ns10:Originalns10:RegisteredOffice2022-09-012023-08-3110907715ns10:Original2022-08-3110907715ns10:Originalns5:CurrentFinancialInstruments2023-08-3110907715ns10:Originalns5:CurrentFinancialInstruments2022-08-3110907715ns10:Originalns5:Non-currentFinancialInstruments2023-08-3110907715ns10:Originalns5:Non-currentFinancialInstruments2022-08-3110907715ns5:ShareCapitalns10:Original2023-08-3110907715ns5:ShareCapitalns10:Original2022-08-3110907715ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-08-3110907715ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-08-3110907715ns10:Originalns5:PlantMachinery2022-09-012023-08-3110907715ns10:Original2021-09-012022-08-3110907715ns10:Originalns5:PlantMachinery2022-08-3110907715ns10:Originalns5:PlantMachinery2023-08-3110907715ns10:Originalns5:PlantMachinery2022-08-3110907715ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-08-3110907715ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-08-31
REGISTERED NUMBER: 10907715 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 August 2023

for

Orca Medical Limited

Orca Medical Limited (Registered number: 10907715)






Contents of the Financial Statements
for the Year Ended 31 August 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Orca Medical Limited

Company Information
for the Year Ended 31 August 2023







DIRECTORS: R Fowler
D Ogg





REGISTERED OFFICE: Future Space University West Of England
UWE North Gate
Filton Road
Bristol
BS34 8RB





REGISTERED NUMBER: 10907715 (England and Wales)





ACCOUNTANTS: Kingscote Accountancy Limited
77A Alma Road
Clifton
Bristol
BS8 2DP

Orca Medical Limited (Registered number: 10907715)

Balance Sheet
31 August 2023

31.8.23 31.8.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 142,235 150,028

CURRENT ASSETS
Stocks 104,449 75,379
Debtors 5 182,934 282,331
Cash at bank 346,663 181,935
634,046 539,645
CREDITORS
Amounts falling due within one year 6 163,248 303,155
NET CURRENT ASSETS 470,798 236,490
TOTAL ASSETS LESS CURRENT
LIABILITIES

613,033

386,518

CREDITORS
Amounts falling due after more than one year 7 (17,500 ) (33,437 )

PROVISIONS FOR LIABILITIES (34,078 ) (28,505 )
NET ASSETS 561,455 324,576

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 561,453 324,574
561,455 324,576

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Orca Medical Limited (Registered number: 10907715)

Balance Sheet - continued
31 August 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 November 2023 and were signed on its behalf by:





R Fowler - Director


Orca Medical Limited (Registered number: 10907715)

Notes to the Financial Statements
for the Year Ended 31 August 2023

1. STATUTORY INFORMATION

Orca Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Orca Medical Limited (Registered number: 10907715)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2022 - 7 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 September 2022 223,622
Additions 102,956
Disposals (88,400 )
At 31 August 2023 238,178
DEPRECIATION
At 1 September 2022 73,594
Charge for year 51,640
Eliminated on disposal (29,291 )
At 31 August 2023 95,943
NET BOOK VALUE
At 31 August 2023 142,235
At 31 August 2022 150,028

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.23 31.8.22
£    £   
Trade debtors 57,605 56,921
Amounts owed by group undertakings 122,242 116,015
Other debtors 3,087 109,395
182,934 282,331

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.23 31.8.22
£    £   
Bank loans and overdrafts 15,937 33,748
Trade creditors 57,193 47,701
Amounts owed to group undertakings - 154,332
Taxation and social security 48,581 24,250
Other creditors 41,537 43,124
163,248 303,155

Orca Medical Limited (Registered number: 10907715)

Notes to the Financial Statements - continued
for the Year Ended 31 August 2023

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.8.23 31.8.22
£    £   
Bank loans 17,500 33,437

8. RELATED PARTY DISCLOSURES

During the year R Fowler introduced working capital into the Company of £9,672 [2022: £57]. As at the
balance sheet date, Orca Medical Limited owed R Fowler £9,874 [2022: £10,339].

During the year D Ogg introduced working capital into the Company of £9,588 [2022: £Nil]. As at the
balance sheet date, Orca Medical Limited owed D Ogg £31,152 [2022: £31,589].

As at the balance sheet date, Orca Medical Limited owed Healcerion EMEA Limited £Nil [2022: £5,200].

As at the balance sheet date, Orca Medical Limited owed Refract Marketing Services Limited £Nil [2022: £149,132].

As at the balance sheet date, Orca Resource Limited owed Orca Medical Limited £122,242 [2022: £116,015].

Orca Medical Limited, Refract Marketing Services Limited, and Orca Resource Limited are a connected companies by virtue of their directors R Fowler and D Ogg.